Patent cements Dewpoint’s leadership in the discovery of biomolecular condensate modulators to treat diseases New platform technology allows identification of molecules which alter specific components of biomolecular condensates with high precision BOSTON, May 25, 2022 /PRNewswire/ — Dewpoint Therapeutics Inc., […]
Dewpoint Therapeutics Granted Foundational Platform Technology Patent by US Patent Office
Categories:
Continue reading